"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","description.1","data_processing","platform_id","contact_name","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","disease state:ch1","individual:ch1","order in which blood was collected during treatment:ch1","sample:ch1","treatment:ch1"
"GSM2281309","045-002","GSM2281309","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 045","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","567","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281309/suppl/GSM2281309_SH46G31_Cell1_20150115_2238_1Color_IntegratedResult.txt.gz","2555","HCC","patient 045","2","serum","HCC operation"
"GSM2281310","054-002","GSM2281310","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 054","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","569","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281310/suppl/GSM2281310_SH46G31_Cell2_20150115_2239_1Color_IntegratedResult.txt.gz","2555","HCC","patient 054","2","serum","HCC operation"
"GSM2281311","032-001","GSM2281311","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 032","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","572","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281311/suppl/GSM2281311_SH46G31_Cell3_20150115_2240_1Color_IntegratedResult.txt.gz","2555","HCC","patient 032","1","serum","HCC operation"
"GSM2281312","054-003","GSM2281312","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 054","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","574","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281312/suppl/GSM2281312_SH46G31_Cell4_20150115_2241_1Color_IntegratedResult.txt.gz","2555","HCC","patient 054","3","serum","HCC operation"
"GSM2281313","044-001","GSM2281313","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 044","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","576","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281313/suppl/GSM2281313_SH46G34_Cell1_20150115_2242_1Color_IntegratedResult.txt.gz","2555","HCC","patient 044","1","serum","HCC operation"
"GSM2281314","032-002","GSM2281314","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 032","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","577","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281314/suppl/GSM2281314_SH46G34_Cell2_20150115_2243_1Color_IntegratedResult.txt.gz","2555","HCC","patient 032","2","serum","HCC operation"
"GSM2281315","022-001","GSM2281315","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 022","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","582","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281315/suppl/GSM2281315_SH4XG05_Cell1_20150115_2246_1Color_IntegratedResult.txt.gz","2555","HCC","patient 022","1","serum","HCC operation"
"GSM2281316","022-003","GSM2281316","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 022","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","586","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281316/suppl/GSM2281316_SH4XG05_Cell2_20150115_2247_1Color_IntegratedResult.txt.gz","2555","HCC","patient 022","3","serum","HCC operation"
"GSM2281317","024-001","GSM2281317","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 024","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","587","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281317/suppl/GSM2281317_SH4XG05_Cell3_20150115_2248_1Color_IntegratedResult.txt.gz","2555","HCC","patient 024","1","serum","HCC operation"
"GSM2281318","024-002","GSM2281318","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 024","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","589","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281318/suppl/GSM2281318_SH4XG05_Cell4_20150115_2249_1Color_IntegratedResult.txt.gz","2555","HCC","patient 024","2","serum","HCC operation"
"GSM2281319","106-001","GSM2281319","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 106","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","84","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281319/suppl/GSM2281319_SH4XL37_Cell1_20150108_1925_1Color_IntegratedResult.txt.gz","2555","HCC","patient 106","1","serum","HCC operation"
"GSM2281320","086-001","GSM2281320","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 086","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","85","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281320/suppl/GSM2281320_SH4XL37_Cell2_20150108_1926_1Color_IntegratedResult.txt.gz","2555","HCC","patient 086","1","serum","HCC operation"
"GSM2281321","083-001","GSM2281321","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 083","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","86","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281321/suppl/GSM2281321_SH4XL37_Cell3_20150108_1927_1Color_IntegratedResult.txt.gz","2555","HCC","patient 083","1","serum","HCC operation"
"GSM2281322","107-001","GSM2281322","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 107","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","87","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281322/suppl/GSM2281322_SH4XL37_Cell4_20150108_1928_1Color_IntegratedResult.txt.gz","2555","HCC","patient 107","1","serum","HCC operation"
"GSM2281323","101-002","GSM2281323","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 101","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","89","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281323/suppl/GSM2281323_SH4XL40_Cell1_20150108_1929_1Color_IntegratedResult.txt.gz","2555","HCC","patient 101","2","serum","HCC operation"
"GSM2281324","106-002","GSM2281324","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 106","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","91","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281324/suppl/GSM2281324_SH4XL40_Cell2_20150108_1930_1Color_IntegratedResult.txt.gz","2555","HCC","patient 106","2","serum","HCC operation"
"GSM2281325","086-002","GSM2281325","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 086","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","92","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281325/suppl/GSM2281325_SH4XL40_Cell3_20150108_1931_1Color_IntegratedResult.txt.gz","2555","HCC","patient 086","2","serum","HCC operation"
"GSM2281326","063-002","GSM2281326","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 063","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","93","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281326/suppl/GSM2281326_SH4XL40_Cell4_20150108_1932_1Color_IntegratedResult.txt.gz","2555","HCC","patient 063","2","serum","HCC operation"
"GSM2281327","014-001","GSM2281327","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 014","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","94","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281327/suppl/GSM2281327_SH4XL41_Cell1_20150108_1933_1Color_IntegratedResult.txt.gz","2555","HCC","patient 014","1","serum","HCC operation"
"GSM2281328","102-003","GSM2281328","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 102","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","95","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281328/suppl/GSM2281328_SH4XL41_Cell2_20150108_1934_1Color_IntegratedResult.txt.gz","2555","HCC","patient 102","3","serum","HCC operation"
"GSM2281329","021-002","GSM2281329","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 021","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","98","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281329/suppl/GSM2281329_SH4XL41_Cell3_20150108_1935_1Color_IntegratedResult.txt.gz","2555","HCC","patient 021","2","serum","HCC operation"
"GSM2281330","083-002","GSM2281330","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 083","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","101","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281330/suppl/GSM2281330_SH4XL41_Cell4_20150108_1936_1Color_IntegratedResult.txt.gz","2555","HCC","patient 083","2","serum","HCC operation"
"GSM2281331","112-002","GSM2281331","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 112","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","102","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281331/suppl/GSM2281331_SH4XL44_Cell1_20150108_1937_1Color_IntegratedResult.txt.gz","2555","HCC","patient 112","2","serum","HCC operation"
"GSM2281332","035-003","GSM2281332","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 035","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","103","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281332/suppl/GSM2281332_SH4XL44_Cell2_20150108_1938_1Color_IntegratedResult.txt.gz","2555","HCC","patient 035","3","serum","HCC operation"
"GSM2281333","084-001","GSM2281333","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 084","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","104","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281333/suppl/GSM2281333_SH4XL44_Cell3_20150108_1939_1Color_IntegratedResult.txt.gz","2555","HCC","patient 084","1","serum","HCC operation"
"GSM2281334","028-002","GSM2281334","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 028","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","105","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281334/suppl/GSM2281334_SH4XL44_Cell4_20150108_1940_1Color_IntegratedResult.txt.gz","2555","HCC","patient 028","2","serum","HCC operation"
"GSM2281335","029-001","GSM2281335","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 029","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","106","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281335/suppl/GSM2281335_SH4XL45_Cell1_20150108_1941_1Color_IntegratedResult.txt.gz","2555","HCC","patient 029","1","serum","HCC operation"
"GSM2281336","014-002","GSM2281336","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 014","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","108","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281336/suppl/GSM2281336_SH4XL45_Cell2_20150108_1942_1Color_IntegratedResult.txt.gz","2555","HCC","patient 014","2","serum","HCC operation"
"GSM2281337","114-001","GSM2281337","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 114","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","110","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281337/suppl/GSM2281337_SH4XL45_Cell3_20150108_1943_1Color_IntegratedResult.txt.gz","2555","HCC","patient 114","1","serum","HCC operation"
"GSM2281338","090-001","GSM2281338","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 090","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","111","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281338/suppl/GSM2281338_SH4XL45_Cell4_20150108_1944_1Color_IntegratedResult.txt.gz","2555","HCC","patient 090","1","serum","HCC operation"
"GSM2281339","051-001","GSM2281339","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 051","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","112","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281339/suppl/GSM2281339_SH4XL49_Cell1_20150108_1945_1Color_IntegratedResult.txt.gz","2555","HCC","patient 051","1","serum","HCC operation"
"GSM2281340","114-002","GSM2281340","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 114","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","114","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281340/suppl/GSM2281340_SH4XL49_Cell2_20150108_1946_1Color_IntegratedResult.txt.gz","2555","HCC","patient 114","2","serum","HCC operation"
"GSM2281341","083-003","GSM2281341","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 083","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","115","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281341/suppl/GSM2281341_SH4XL49_Cell3_20150108_1947_1Color_IntegratedResult.txt.gz","2555","HCC","patient 083","3","serum","HCC operation"
"GSM2281342","090-002","GSM2281342","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 090","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","116","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281342/suppl/GSM2281342_SH4XL49_Cell4_20150108_1948_1Color_IntegratedResult.txt.gz","2555","HCC","patient 090","2","serum","HCC operation"
"GSM2281343","042-001","GSM2281343","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 042","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","2","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281343/suppl/GSM2281343_SH4XL52_Cell1_20150109_1210_1Color_IntegratedResult.txt.gz","2555","HCC","patient 042","1","serum","HCC operation"
"GSM2281344","075-001","GSM2281344","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 075","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","3","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281344/suppl/GSM2281344_SH4XL52_Cell2_20150109_1211_1Color_IntegratedResult.txt.gz","2555","HCC","patient 075","1","serum","HCC operation"
"GSM2281345","102-001","GSM2281345","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 102","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","5","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281345/suppl/GSM2281345_SH4XL52_Cell3_20150109_1212_1Color_IntegratedResult.txt.gz","2555","HCC","patient 102","1","serum","HCC operation"
"GSM2281346","075-002","GSM2281346","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 075","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","6","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281346/suppl/GSM2281346_SH4XL52_Cell4_20150109_1213_1Color_IntegratedResult.txt.gz","2555","HCC","patient 075","2","serum","HCC operation"
"GSM2281347","035-001","GSM2281347","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 035","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","7","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281347/suppl/GSM2281347_SH4XL53_Cell1_20150109_1214_1Color_IntegratedResult.txt.gz","2555","HCC","patient 035","1","serum","HCC operation"
"GSM2281348","102-002","GSM2281348","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 102","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","8","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281348/suppl/GSM2281348_SH4XL53_Cell2_20150109_1215_1Color_IntegratedResult.txt.gz","2555","HCC","patient 102","2","serum","HCC operation"
"GSM2281349","035-002","GSM2281349","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 035","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","11","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281349/suppl/GSM2281349_SH4XL53_Cell3_20150109_1216_1Color_IntegratedResult.txt.gz","2555","HCC","patient 035","2","serum","HCC operation"
"GSM2281350","072-001","GSM2281350","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 072","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","27","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281350/suppl/GSM2281350_SH4XL53_Cell4_20150109_1217_1Color_IntegratedResult.txt.gz","2555","HCC","patient 072","1","serum","HCC operation"
"GSM2281351","073-001","GSM2281351","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 073","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","28","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281351/suppl/GSM2281351_SH4XL56_Cell1_20150109_1218_1Color_IntegratedResult.txt.gz","2555","HCC","patient 073","1","serum","HCC operation"
"GSM2281352","073-002","GSM2281352","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 073","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","36","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281352/suppl/GSM2281352_SH4XL56_Cell2_20150109_1219_1Color_IntegratedResult.txt.gz","2555","HCC","patient 073","2","serum","HCC operation"
"GSM2281353","035-004","GSM2281353","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 035","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","37","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281353/suppl/GSM2281353_SH4XL56_Cell3_20150109_1220_1Color_IntegratedResult.txt.gz","2555","HCC","patient 035","4","serum","HCC operation"
"GSM2281355","072-002","GSM2281355","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 072","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","45","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281355/suppl/GSM2281355_SH4XL56_Cell4_20150109_1221_1Color_IntegratedResult.txt.gz","2555","HCC","patient 072","2","serum","HCC operation"
"GSM2281357","112-001","GSM2281357","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 112","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","46","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281357/suppl/GSM2281357_SH4XL57_Cell1_20150109_1222_1Color_IntegratedResult.txt.gz","2555","HCC","patient 112","1","serum","HCC operation"
"GSM2281358","063-001","GSM2281358","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 063","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","47","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281358/suppl/GSM2281358_SH4XL57_Cell2_20150109_1223_1Color_IntegratedResult.txt.gz","2555","HCC","patient 063","1","serum","HCC operation"
"GSM2281359","073-003","GSM2281359","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 073","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","53","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281359/suppl/GSM2281359_SH4XL57_Cell3_20150109_1224_1Color_IntegratedResult.txt.gz","2555","HCC","patient 073","3","serum","HCC operation"
"GSM2281360","012-001","GSM2281360","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 012","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","55","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281360/suppl/GSM2281360_SH4XL57_Cell4_20150109_1225_1Color_IntegratedResult.txt.gz","2555","HCC","patient 012","1","serum","HCC operation"
"GSM2281362","101-001","GSM2281362","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 101","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","56","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281362/suppl/GSM2281362_SH4XL60_Cell1_20150109_1226_1Color_IntegratedResult.txt.gz","2555","HCC","patient 101","1","serum","HCC operation"
"GSM2281363","028-001","GSM2281363","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 028","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","57","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281363/suppl/GSM2281363_SH4XL60_Cell2_20150109_1227_1Color_IntegratedResult.txt.gz","2555","HCC","patient 028","1","serum","HCC operation"
"GSM2281365","063-003","GSM2281365","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 063","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","58","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281365/suppl/GSM2281365_SH4XL60_Cell3_20150109_1228_1Color_IntegratedResult.txt.gz","2555","HCC","patient 063","3","serum","HCC operation"
"GSM2281366","012-002","GSM2281366","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 012","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","63","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281366/suppl/GSM2281366_SH4XL60_Cell4_20150109_1229_1Color_IntegratedResult.txt.gz","2555","HCC","patient 012","2","serum","HCC operation"
"GSM2281367","101-003","GSM2281367","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 101","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","65","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281367/suppl/GSM2281367_SH4XQ01_Cell1_20150109_1230_1Color_IntegratedResult.txt.gz","2555","HCC","patient 101","3","serum","HCC operation"
"GSM2281368","072-003","GSM2281368","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 072","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","66","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281368/suppl/GSM2281368_SH4XQ01_Cell2_20150109_1231_1Color_IntegratedResult.txt.gz","2555","HCC","patient 072","3","serum","HCC operation"
"GSM2281369","112-003","GSM2281369","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 112","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","68","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281369/suppl/GSM2281369_SH4XQ01_Cell3_20150109_1232_1Color_IntegratedResult.txt.gz","2555","HCC","patient 112","3","serum","HCC operation"
"GSM2281370","021-001","GSM2281370","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 021","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","74","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281370/suppl/GSM2281370_SH4XQ02_Cell1_20150109_1234_1Color_IntegratedResult.txt.gz","2555","HCC","patient 021","1","serum","HCC operation"
"GSM2281371","075-003","GSM2281371","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 075","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","78","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281371/suppl/GSM2281371_SH4XQ02_Cell2_20150109_1235_1Color_IntegratedResult.txt.gz","2555","HCC","patient 075","3","serum","HCC operation"
"GSM2281372","021-003","GSM2281372","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 021","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","79","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281372/suppl/GSM2281372_SH4XQ02_Cell3_20150109_1236_1Color_IntegratedResult.txt.gz","2555","HCC","patient 021","3","serum","HCC operation"
"GSM2281373","012-003","GSM2281373","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 012","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","82","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281373/suppl/GSM2281373_SH4XQ03_Cell1_20150109_1238_1Color_IntegratedResult.txt.gz","2555","HCC","patient 012","3","serum","HCC operation"
"GSM2281374","084-002","GSM2281374","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 084","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","117","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281374/suppl/GSM2281374_SH4XQ04_Cell1_20150109_1710_1Color_IntegratedResult.txt.gz","2555","HCC","patient 084","2","serum","HCC operation"
"GSM2281375","011-001","GSM2281375","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 011","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","119","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281375/suppl/GSM2281375_SH4XQ04_Cell2_20150109_1711_1Color_IntegratedResult.txt.gz","2555","HCC","patient 011","1","serum","HCC operation"
"GSM2281376","014-003","GSM2281376","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 014","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","121","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281376/suppl/GSM2281376_SH4XQ04_Cell3_20150109_1712_1Color_IntegratedResult.txt.gz","2555","HCC","patient 014","3","serum","HCC operation"
"GSM2281377","029-002","GSM2281377","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 029","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","122","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281377/suppl/GSM2281377_SH4XQ04_Cell4_20150109_1713_1Color_IntegratedResult.txt.gz","2555","HCC","patient 029","2","serum","HCC operation"
"GSM2281378","011-002","GSM2281378","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 011","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","125","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281378/suppl/GSM2281378_SH4XQ05_Cell1_20150109_1714_1Color_IntegratedResult.txt.gz","2555","HCC","patient 011","2","serum","HCC operation"
"GSM2281379","039-001","GSM2281379","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 039","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","127","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281379/suppl/GSM2281379_SH4XQ05_Cell2_20150109_1715_1Color_IntegratedResult.txt.gz","2555","HCC","patient 039","1","serum","HCC operation"
"GSM2281380","070-001","GSM2281380","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 070","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","128","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281380/suppl/GSM2281380_SH4XQ05_Cell3_20150109_1716_1Color_IntegratedResult.txt.gz","2555","HCC","patient 070","1","serum","HCC operation"
"GSM2281381","057-001","GSM2281381","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 057","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","129","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281381/suppl/GSM2281381_SH4XQ05_Cell4_20150109_1717_1Color_IntegratedResult.txt.gz","2555","HCC","patient 057","1","serum","HCC operation"
"GSM2281382","011-003","GSM2281382","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 011","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","134","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281382/suppl/GSM2281382_SH4XQ07_Cell1_20150109_1718_1Color_IntegratedResult.txt.gz","2555","HCC","patient 011","3","serum","HCC operation"
"GSM2281383","101-004","GSM2281383","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 101","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","135","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281383/suppl/GSM2281383_SH4XQ07_Cell2_20150109_1719_1Color_IntegratedResult.txt.gz","2555","HCC","patient 101","4","serum","HCC operation"
"GSM2281384","057-002","GSM2281384","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 057","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","139","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281384/suppl/GSM2281384_SH4XQ07_Cell3_20150109_1720_1Color_IntegratedResult.txt.gz","2555","HCC","patient 057","2","serum","HCC operation"
"GSM2281385","070-002","GSM2281385","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 070","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","140","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281385/suppl/GSM2281385_SH4XQ07_Cell4_20150109_1721_1Color_IntegratedResult.txt.gz","2555","HCC","patient 070","2","serum","HCC operation"
"GSM2281386","042-002","GSM2281386","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 042","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","142","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281386/suppl/GSM2281386_SH4XQ08_Cell1_20150109_1722_1Color_IntegratedResult.txt.gz","2555","HCC","patient 042","2","serum","HCC operation"
"GSM2281387","051-002","GSM2281387","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 051","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","143","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281387/suppl/GSM2281387_SH4XQ08_Cell2_20150109_1723_1Color_IntegratedResult.txt.gz","2555","HCC","patient 051","2","serum","HCC operation"
"GSM2281388","070-003","GSM2281388","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 070","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","144","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281388/suppl/GSM2281388_SH4XQ08_Cell3_20150109_1724_1Color_IntegratedResult.txt.gz","2555","HCC","patient 070","3","serum","HCC operation"
"GSM2281389","090-003","GSM2281389","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 090","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","145","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281389/suppl/GSM2281389_SH4XQ08_Cell4_20150109_1725_1Color_IntegratedResult.txt.gz","2555","HCC","patient 090","3","serum","HCC operation"
"GSM2281390","048-001","GSM2281390","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 048","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","146","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281390/suppl/GSM2281390_SH4XQ09_Cell1_20150109_1726_1Color_IntegratedResult.txt.gz","2555","HCC","patient 048","1","serum","HCC operation"
"GSM2281391","028-003","GSM2281391","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 028","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","147","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281391/suppl/GSM2281391_SH4XQ09_Cell2_20150109_1727_1Color_IntegratedResult.txt.gz","2555","HCC","patient 028","3","serum","HCC operation"
"GSM2281392","114-003","GSM2281392","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 114","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","148","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281392/suppl/GSM2281392_SH4XQ09_Cell3_20150109_1728_1Color_IntegratedResult.txt.gz","2555","HCC","patient 114","3","serum","HCC operation"
"GSM2281393","106-003","GSM2281393","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 106","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","150","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281393/suppl/GSM2281393_SH4XQ09_Cell4_20150109_1729_1Color_IntegratedResult.txt.gz","2555","HCC","patient 106","3","serum","HCC operation"
"GSM2281394","048-002","GSM2281394","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 048","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","152","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281394/suppl/GSM2281394_SH4XQ11_Cell1_20150109_1730_1Color_IntegratedResult.txt.gz","2555","HCC","patient 048","2","serum","HCC operation"
"GSM2281395","107-002","GSM2281395","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 107","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","153","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281395/suppl/GSM2281395_SH4XQ11_Cell2_20150109_1731_1Color_IntegratedResult.txt.gz","2555","HCC","patient 107","2","serum","HCC operation"
"GSM2281396","031-001","GSM2281396","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 031","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","154","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281396/suppl/GSM2281396_SH4XQ11_Cell3_20150109_1732_1Color_IntegratedResult.txt.gz","2555","HCC","patient 031","1","serum","HCC operation"
"GSM2281397","063-004","GSM2281397","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 063","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","155","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281397/suppl/GSM2281397_SH4XQ11_Cell4_20150109_1733_1Color_IntegratedResult.txt.gz","2555","HCC","patient 063","4","serum","HCC operation"
"GSM2281398","057-003","GSM2281398","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 057","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","156","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281398/suppl/GSM2281398_SH4XQ12_Cell1_20150109_1734_1Color_IntegratedResult.txt.gz","2555","HCC","patient 057","3","serum","HCC operation"
"GSM2281399","107-003","GSM2281399","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 107","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","157","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281399/suppl/GSM2281399_SH4XQ12_Cell2_20150109_1735_1Color_IntegratedResult.txt.gz","2555","HCC","patient 107","3","serum","HCC operation"
"GSM2281400","031-002","GSM2281400","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 031","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","159","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281400/suppl/GSM2281400_SH4XQ12_Cell4_20150109_1737_1Color_IntegratedResult.txt.gz","2555","HCC","patient 031","2","serum","HCC operation"
"GSM2281401","036-001","GSM2281401","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 036","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","160","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281401/suppl/GSM2281401_SH4XQ13_Cell1_20150109_1738_1Color_IntegratedResult.txt.gz","2555","HCC","patient 036","1","serum","HCC operation"
"GSM2281402","086-003","GSM2281402","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 086","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","161","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281402/suppl/GSM2281402_SH4XQ13_Cell2_20150109_1739_1Color_IntegratedResult.txt.gz","2555","HCC","patient 086","3","serum","HCC operation"
"GSM2281403","039-002","GSM2281403","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 039","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","162","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281403/suppl/GSM2281403_SH4XQ13_Cell3_20150109_1740_1Color_IntegratedResult.txt.gz","2555","HCC","patient 039","2","serum","HCC operation"
"GSM2281404","048-003","GSM2281404","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 048","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","163","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281404/suppl/GSM2281404_SH4XQ13_Cell4_20150109_1741_1Color_IntegratedResult.txt.gz","2555","HCC","patient 048","3","serum","HCC operation"
"GSM2281405","051-003","GSM2281405","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 051","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","164","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281405/suppl/GSM2281405_SH4XQ14_Cell1_20150109_1742_1Color_IntegratedResult.txt.gz","2555","HCC","patient 051","3","serum","HCC operation"
"GSM2281406","036-002","GSM2281406","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 036","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","166","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281406/suppl/GSM2281406_SH4XQ14_Cell2_20150109_1743_1Color_IntegratedResult.txt.gz","2555","HCC","patient 036","2","serum","HCC operation"
"GSM2281407","072-004","GSM2281407","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 072","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","167","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281407/suppl/GSM2281407_SH4XQ14_Cell3_20150109_1744_1Color_IntegratedResult.txt.gz","2555","HCC","patient 072","4","serum","HCC operation"
"GSM2281408","093-001","GSM2281408","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 093","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","171","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281408/suppl/GSM2281408_SH4XQ14_Cell4_20150109_1745_1Color_IntegratedResult.txt.gz","2555","HCC","patient 093","1","serum","HCC operation"
"GSM2281409","015-001","GSM2281409","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 015","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","173","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281409/suppl/GSM2281409_SH4XQ15_Cell1_20150109_1746_1Color_IntegratedResult.txt.gz","2555","HCC","patient 015","1","serum","HCC operation"
"GSM2281410","016-001","GSM2281410","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 016","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","174","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281410/suppl/GSM2281410_SH4XQ15_Cell2_20150109_1747_1Color_IntegratedResult.txt.gz","2555","HCC","patient 016","1","serum","HCC operation"
"GSM2281411","036-003","GSM2281411","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 036","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","175","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281411/suppl/GSM2281411_SH4XQ15_Cell3_20150109_1748_1Color_IntegratedResult.txt.gz","2555","HCC","patient 036","3","serum","HCC operation"
"GSM2281412","021-004","GSM2281412","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 021","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","176","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281412/suppl/GSM2281412_SH4XQ15_Cell4_20150109_1749_1Color_IntegratedResult.txt.gz","2555","HCC","patient 021","4","serum","HCC operation"
"GSM2281413","015-002","GSM2281413","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 015","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","182","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281413/suppl/GSM2281413_SH4XQ17_Cell1_20150109_1750_1Color_IntegratedResult.txt.gz","2555","HCC","patient 015","2","serum","HCC operation"
"GSM2281414","093-002","GSM2281414","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 093","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","183","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281414/suppl/GSM2281414_SH4XQ17_Cell2_20150109_1751_1Color_IntegratedResult.txt.gz","2555","HCC","patient 093","2","serum","HCC operation"
"GSM2281415","111-001","GSM2281415","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 111","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","184","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281415/suppl/GSM2281415_SH4XQ17_Cell3_20150109_1752_1Color_IntegratedResult.txt.gz","2555","HCC","patient 111","1","serum","HCC operation"
"GSM2281416","016-002","GSM2281416","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 016","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","186","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281416/suppl/GSM2281416_SH4XQ17_Cell4_20150109_1753_1Color_IntegratedResult.txt.gz","2555","HCC","patient 016","2","serum","HCC operation"
"GSM2281417","111-002","GSM2281417","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 111","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","187","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281417/suppl/GSM2281417_SH4XQ18_Cell1_20150109_1754_1Color_IntegratedResult.txt.gz","2555","HCC","patient 111","2","serum","HCC operation"
"GSM2281418","038-001","GSM2281418","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 038","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","189","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281418/suppl/GSM2281418_SH4XQ18_Cell2_20150109_1755_1Color_IntegratedResult.txt.gz","2555","HCC","patient 038","1","serum","HCC operation"
"GSM2281419","083-004","GSM2281419","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 083","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","192","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281419/suppl/GSM2281419_SH4XQ18_Cell3_20150109_1756_1Color_IntegratedResult.txt.gz","2555","HCC","patient 083","4","serum","HCC operation"
"GSM2281420","111-003","GSM2281420","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 111","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","194","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281420/suppl/GSM2281420_SH4XQ18_Cell4_20150109_1757_1Color_IntegratedResult.txt.gz","2555","HCC","patient 111","3","serum","HCC operation"
"GSM2281421","078-001","GSM2281421","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 078","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","200","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281421/suppl/GSM2281421_SH4XQ19_Cell1_20150109_1758_1Color_IntegratedResult.txt.gz","2555","HCC","patient 078","1","serum","HCC operation"
"GSM2281422","061-001","GSM2281422","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 061","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","201","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281422/suppl/GSM2281422_SH4XQ19_Cell2_20150109_1759_1Color_IntegratedResult.txt.gz","2555","HCC","patient 061","1","serum","HCC operation"
"GSM2281423","038-002","GSM2281423","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 038","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","202","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281423/suppl/GSM2281423_SH4XQ19_Cell3_20150109_1800_1Color_IntegratedResult.txt.gz","2555","HCC","patient 038","2","serum","HCC operation"
"GSM2281424","018-001","GSM2281424","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 018","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","203","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281424/suppl/GSM2281424_SH4XQ19_Cell4_20150109_1801_1Color_IntegratedResult.txt.gz","2555","HCC","patient 018","1","serum","HCC operation"
"GSM2281425","084-003","GSM2281425","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 084","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","204","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281425/suppl/GSM2281425_SH4XQ20_Cell1_20150109_1802_1Color_IntegratedResult.txt.gz","2555","HCC","patient 084","3","serum","HCC operation"
"GSM2281426","014-004","GSM2281426","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 014","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","207","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281426/suppl/GSM2281426_SH4XQ20_Cell2_20150109_1803_1Color_IntegratedResult.txt.gz","2555","HCC","patient 014","4","serum","HCC operation"
"GSM2281427","108-001","GSM2281427","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 108","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","209","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281427/suppl/GSM2281427_SH4XQ20_Cell3_20150109_1804_1Color_IntegratedResult.txt.gz","2555","HCC","patient 108","1","serum","HCC operation"
"GSM2281428","046-001","GSM2281428","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 046","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","214","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281428/suppl/GSM2281428_SH4XQ20_Cell4_20150109_1805_1Color_IntegratedResult.txt.gz","2555","HCC","patient 046","1","serum","HCC operation"
"GSM2281429","078-002","GSM2281429","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 078","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","215","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281429/suppl/GSM2281429_SH4XQ21_Cell1_20150109_1806_1Color_IntegratedResult.txt.gz","2555","HCC","patient 078","2","serum","HCC operation"
"GSM2281430","080-001","GSM2281430","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 080","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","216","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281430/suppl/GSM2281430_SH4XQ21_Cell2_20150109_1807_1Color_IntegratedResult.txt.gz","2555","HCC","patient 080","1","serum","HCC operation"
"GSM2281431","089-001","GSM2281431","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 089","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","217","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281431/suppl/GSM2281431_SH4XQ21_Cell3_20150109_1808_1Color_IntegratedResult.txt.gz","2555","HCC","patient 089","1","serum","HCC operation"
"GSM2281432","104-001","GSM2281432","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 104","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","219","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281432/suppl/GSM2281432_SH4XQ21_Cell4_20150109_1809_1Color_IntegratedResult.txt.gz","2555","HCC","patient 104","1","serum","HCC operation"
"GSM2281433","080-002","GSM2281433","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 080","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","221","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281433/suppl/GSM2281433_SH4XQ22_Cell1_20150109_1810_1Color_IntegratedResult.txt.gz","2555","HCC","patient 080","2","serum","HCC operation"
"GSM2281434","108-002","GSM2281434","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 108","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","222","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281434/suppl/GSM2281434_SH4XQ22_Cell2_20150109_1811_1Color_IntegratedResult.txt.gz","2555","HCC","patient 108","2","serum","HCC operation"
"GSM2281435","018-002","GSM2281435","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 018","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","223","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281435/suppl/GSM2281435_SH4XQ22_Cell3_20150109_1812_1Color_IntegratedResult.txt.gz","2555","HCC","patient 018","2","serum","HCC operation"
"GSM2281436","090-004","GSM2281436","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 090","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","227","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281436/suppl/GSM2281436_SH4XQ22_Cell4_20150109_1813_1Color_IntegratedResult.txt.gz","2555","HCC","patient 090","4","serum","HCC operation"
"GSM2281437","089-002","GSM2281437","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 089","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","235","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281437/suppl/GSM2281437_SH4XQ23_Cell1_20150109_1818_1Color_IntegratedResult.txt.gz","2555","HCC","patient 089","2","serum","HCC operation"
"GSM2281438","046-002","GSM2281438","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 046","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","236","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281438/suppl/GSM2281438_SH4XQ23_Cell2_20150109_1819_1Color_IntegratedResult.txt.gz","2555","HCC","patient 046","2","serum","HCC operation"
"GSM2281439","104-002","GSM2281439","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 104","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","238","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281439/suppl/GSM2281439_SH4XQ23_Cell3_20150109_1820_1Color_IntegratedResult.txt.gz","2555","HCC","patient 104","2","serum","HCC operation"
"GSM2281440","113-001","GSM2281440","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 113","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","240","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281440/suppl/GSM2281440_SH4XQ23_Cell4_20150109_1821_1Color_IntegratedResult.txt.gz","2555","HCC","patient 113","1","serum","HCC operation"
"GSM2281441","104-003","GSM2281441","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 104","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","228","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281441/suppl/GSM2281441_SH4XQ24_Cell1_20150109_1814_1Color_IntegratedResult.txt.gz","2555","HCC","patient 104","3","serum","HCC operation"
"GSM2281442","089-003","GSM2281442","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 089","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","230","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281442/suppl/GSM2281442_SH4XQ24_Cell2_20150109_1815_1Color_IntegratedResult.txt.gz","2555","HCC","patient 089","3","serum","HCC operation"
"GSM2281443","039-003","GSM2281443","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 039","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","231","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281443/suppl/GSM2281443_SH4XQ24_Cell3_20150109_1816_1Color_IntegratedResult.txt.gz","2555","HCC","patient 039","3","serum","HCC operation"
"GSM2281444","017-001","GSM2281444","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 017","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","234","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281444/suppl/GSM2281444_SH4XQ24_Cell4_20150109_1817_1Color_IntegratedResult.txt.gz","2555","HCC","patient 017","1","serum","HCC operation"
"GSM2281445","113-002","GSM2281445","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 113","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","242","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281445/suppl/GSM2281445_SH4XQ25_Cell1_20150109_1822_1Color_IntegratedResult.txt.gz","2555","HCC","patient 113","2","serum","HCC operation"
"GSM2281446","069-001","GSM2281446","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 069","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","246","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281446/suppl/GSM2281446_SH4XQ25_Cell2_20150109_1823_1Color_IntegratedResult.txt.gz","2555","HCC","patient 069","1","serum","HCC operation"
"GSM2281447","114-004","GSM2281447","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 114","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","249","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281447/suppl/GSM2281447_SH4XQ25_Cell3_20150109_1824_1Color_IntegratedResult.txt.gz","2555","HCC","patient 114","4","serum","HCC operation"
"GSM2281448","068-001","GSM2281448","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 068","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","250","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281448/suppl/GSM2281448_SH4XQ25_Cell4_20150109_1825_1Color_IntegratedResult.txt.gz","2555","HCC","patient 068","1","serum","HCC operation"
"GSM2281449","017-002","GSM2281449","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 017","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","251","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281449/suppl/GSM2281449_SH4XQ26_Cell1_20150109_1826_1Color_IntegratedResult.txt.gz","2555","HCC","patient 017","2","serum","HCC operation"
"GSM2281450","049-001","GSM2281450","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 049","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","252","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281450/suppl/GSM2281450_SH4XQ26_Cell2_20150109_1827_1Color_IntegratedResult.txt.gz","2555","HCC","patient 049","1","serum","HCC operation"
"GSM2281451","068-002","GSM2281451","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 068","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","254","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281451/suppl/GSM2281451_SH4XQ26_Cell3_20150109_1828_1Color_IntegratedResult.txt.gz","2555","HCC","patient 068","2","serum","HCC operation"
"GSM2281452","030-001","GSM2281452","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 030","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","255","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281452/suppl/GSM2281452_SH4XQ26_Cell4_20150109_1829_1Color_IntegratedResult.txt.gz","2555","HCC","patient 030","1","serum","HCC operation"
"GSM2281453","069-002","GSM2281453","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 069","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","256","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281453/suppl/GSM2281453_SH4XQ27_Cell1_20150114_1203_1Color_IntegratedResult.txt.gz","2555","HCC","patient 069","2","serum","HCC operation"
"GSM2281454","069-003","GSM2281454","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 069","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","260","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281454/suppl/GSM2281454_SH4XQ27_Cell2_20150114_1204_1Color_IntegratedResult.txt.gz","2555","HCC","patient 069","3","serum","HCC operation"
"GSM2281455","030-002","GSM2281455","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 030","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","265","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281455/suppl/GSM2281455_SH4XQ27_Cell4_20150114_1206_1Color_IntegratedResult.txt.gz","2555","HCC","patient 030","2","serum","HCC operation"
"GSM2281456","017-003","GSM2281456","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 017","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","266","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281456/suppl/GSM2281456_SH4XQ29_Cell1_20150114_1207_1Color_IntegratedResult.txt.gz","2555","HCC","patient 017","3","serum","HCC operation"
"GSM2281457","076-001","GSM2281457","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 076","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","269","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281457/suppl/GSM2281457_SH4XQ29_Cell2_20150114_1208_1Color_IntegratedResult.txt.gz","2555","HCC","patient 076","1","serum","HCC operation"
"GSM2281458","030-003","GSM2281458","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 030","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","271","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281458/suppl/GSM2281458_SH4XQ29_Cell3_20150114_1209_1Color_IntegratedResult.txt.gz","2555","HCC","patient 030","3","serum","HCC operation"
"GSM2281459","076-002","GSM2281459","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 076","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","272","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281459/suppl/GSM2281459_SH4XQ29_Cell4_20150114_1210_1Color_IntegratedResult.txt.gz","2555","HCC","patient 076","2","serum","HCC operation"
"GSM2281460","047-001","GSM2281460","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 047","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","273","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281460/suppl/GSM2281460_SH4XQ30_Cell1_20150114_1211_1Color_IntegratedResult.txt.gz","2555","HCC","patient 047","1","serum","HCC operation"
"GSM2281461","047-002","GSM2281461","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 047","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","274","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281461/suppl/GSM2281461_SH4XQ30_Cell2_20150114_1212_1Color_IntegratedResult.txt.gz","2555","HCC","patient 047","2","serum","HCC operation"
"GSM2281462","029-003","GSM2281462","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 029","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","275","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281462/suppl/GSM2281462_SH4XQ30_Cell3_20150114_1213_1Color_IntegratedResult.txt.gz","2555","HCC","patient 029","3","serum","HCC operation"
"GSM2281463","036-004","GSM2281463","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 036","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","276","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281463/suppl/GSM2281463_SH4XQ30_Cell4_20150114_1214_1Color_IntegratedResult.txt.gz","2555","HCC","patient 036","4","serum","HCC operation"
"GSM2281464","047-003","GSM2281464","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 047","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","277","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281464/suppl/GSM2281464_SH4XQ31_Cell1_20150114_1215_1Color_IntegratedResult.txt.gz","2555","HCC","patient 047","3","serum","HCC operation"
"GSM2281465","060-001","GSM2281465","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 060","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","297","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281465/suppl/GSM2281465_SH4XQ31_Cell2_20150114_1216_1Color_IntegratedResult.txt.gz","2555","HCC","patient 060","1","serum","HCC operation"
"GSM2281466","109-001","GSM2281466","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 109","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","299","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281466/suppl/GSM2281466_SH4XQ31_Cell3_20150114_1217_1Color_IntegratedResult.txt.gz","2555","HCC","patient 109","1","serum","HCC operation"
"GSM2281467","031-003","GSM2281467","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 031","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","302","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281467/suppl/GSM2281467_SH4XQ31_Cell4_20150114_1218_1Color_IntegratedResult.txt.gz","2555","HCC","patient 031","3","serum","HCC operation"
"GSM2281468","109-002","GSM2281468","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 109","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","304","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281468/suppl/GSM2281468_SH4XQ32_Cell1_20150114_1219_1Color_IntegratedResult.txt.gz","2555","HCC","patient 109","2","serum","HCC operation"
"GSM2281469","060-002","GSM2281469","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 060","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","306","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281469/suppl/GSM2281469_SH4XQ32_Cell2_20150114_1220_1Color_IntegratedResult.txt.gz","2555","HCC","patient 060","2","serum","HCC operation"
"GSM2281470","061-002","GSM2281470","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 061","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","307","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281470/suppl/GSM2281470_SH4XQ32_Cell3_20150114_1221_1Color_IntegratedResult.txt.gz","2555","HCC","patient 061","2","serum","HCC operation"
"GSM2281471","047-004","GSM2281471","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 047","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","312","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281471/suppl/GSM2281471_SH4XQ32_Cell4_20150114_1222_1Color_IntegratedResult.txt.gz","2555","HCC","patient 047","4","serum","HCC operation"
"GSM2281472","060-003","GSM2281472","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 060","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","320","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281472/suppl/GSM2281472_SH4XQ33_Cell1_20150114_1223_1Color_IntegratedResult.txt.gz","2555","HCC","patient 060","3","serum","HCC operation"
"GSM2281473","103-001","GSM2281473","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 103","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","321","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281473/suppl/GSM2281473_SH4XQ33_Cell2_20150114_1224_1Color_IntegratedResult.txt.gz","2555","HCC","patient 103","1","serum","HCC operation"
"GSM2281474","034-001","GSM2281474","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 034","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","322","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281474/suppl/GSM2281474_SH4XQ33_Cell3_20150114_1225_1Color_IntegratedResult.txt.gz","2555","HCC","patient 034","1","serum","HCC operation"
"GSM2281475","034-002","GSM2281475","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 034","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","324","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281475/suppl/GSM2281475_SH4XQ33_Cell4_20150114_1226_1Color_IntegratedResult.txt.gz","2555","HCC","patient 034","2","serum","HCC operation"
"GSM2281476","103-002","GSM2281476","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 103","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","325","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281476/suppl/GSM2281476_SH4XQ34_Cell1_20150114_1227_1Color_IntegratedResult.txt.gz","2555","HCC","patient 103","2","serum","HCC operation"
"GSM2281477","038-003","GSM2281477","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 038","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","326","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281477/suppl/GSM2281477_SH4XQ34_Cell2_20150114_1228_1Color_IntegratedResult.txt.gz","2555","HCC","patient 038","3","serum","HCC operation"
"GSM2281478","046-003","GSM2281478","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 046","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","327","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281478/suppl/GSM2281478_SH4XQ34_Cell3_20150114_1229_1Color_IntegratedResult.txt.gz","2555","HCC","patient 046","3","serum","HCC operation"
"GSM2281479","034-003","GSM2281479","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 034","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","330","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281479/suppl/GSM2281479_SH4XQ34_Cell4_20150114_1230_1Color_IntegratedResult.txt.gz","2555","HCC","patient 034","3","serum","HCC operation"
"GSM2281480","109-003","GSM2281480","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 109","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","331","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281480/suppl/GSM2281480_SH4XQ35_Cell1_20150114_1231_1Color_IntegratedResult.txt.gz","2555","HCC","patient 109","3","serum","HCC operation"
"GSM2281481","049-002","GSM2281481","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 049","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","332","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281481/suppl/GSM2281481_SH4XQ35_Cell2_20150114_1232_1Color_IntegratedResult.txt.gz","2555","HCC","patient 049","2","serum","HCC operation"
"GSM2281482","087-001","GSM2281482","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 087","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","333","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281482/suppl/GSM2281482_SH4XQ35_Cell3_20150114_1233_1Color_IntegratedResult.txt.gz","2555","HCC","patient 087","1","serum","HCC operation"
"GSM2281483","087-002","GSM2281483","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 087","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","337","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281483/suppl/GSM2281483_SH4XQ35_Cell4_20150114_1234_1Color_IntegratedResult.txt.gz","2555","HCC","patient 087","2","serum","HCC operation"
"GSM2281484","018-003","GSM2281484","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 018","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","341","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281484/suppl/GSM2281484_SH4XQ36_Cell1_20150114_1235_1Color_IntegratedResult.txt.gz","2555","HCC","patient 018","3","serum","HCC operation"
"GSM2281485","087-003","GSM2281485","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 087","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","345","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281485/suppl/GSM2281485_SH4XQ36_Cell2_20150114_1236_1Color_IntegratedResult.txt.gz","2555","HCC","patient 087","3","serum","HCC operation"
"GSM2281486","069-004","GSM2281486","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 069","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","348","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281486/suppl/GSM2281486_SH4XQ36_Cell3_20150114_1237_1Color_IntegratedResult.txt.gz","2555","HCC","patient 069","4","serum","HCC operation"
"GSM2281487","110-001","GSM2281487","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 110","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","350","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281487/suppl/GSM2281487_SH4XQ36_Cell4_20150114_1238_1Color_IntegratedResult.txt.gz","2555","HCC","patient 110","1","serum","HCC operation"
"GSM2281488","019-001","GSM2281488","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 019","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","353","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281488/suppl/GSM2281488_SH4XQ37_Cell1_20150114_1239_1Color_IntegratedResult.txt.gz","2555","HCC","patient 019","1","serum","HCC operation"
"GSM2281489","091-001","GSM2281489","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 091","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","357","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281489/suppl/GSM2281489_SH4XQ37_Cell2_20150114_1240_1Color_IntegratedResult.txt.gz","2555","HCC","patient 091","1","serum","HCC operation"
"GSM2281490","110-002","GSM2281490","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 110","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","358","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281490/suppl/GSM2281490_SH4XQ37_Cell3_20150114_1241_1Color_IntegratedResult.txt.gz","2555","HCC","patient 110","2","serum","HCC operation"
"GSM2281491","019-002","GSM2281491","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 019","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","359","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281491/suppl/GSM2281491_SH4XQ37_Cell4_20150114_1242_1Color_IntegratedResult.txt.gz","2555","HCC","patient 019","2","serum","HCC operation"
"GSM2281492","091-002","GSM2281492","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 091","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","363","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281492/suppl/GSM2281492_SH4XQ38_Cell1_20150114_1711_1Color_IntegratedResult.txt.gz","2555","HCC","patient 091","2","serum","HCC operation"
"GSM2281493","080-003","GSM2281493","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 080","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","364","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281493/suppl/GSM2281493_SH4XQ38_Cell2_20150114_1712_1Color_IntegratedResult.txt.gz","2555","HCC","patient 080","3","serum","HCC operation"
"GSM2281494","033-001","GSM2281494","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 033","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","366","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281494/suppl/GSM2281494_SH4XQ38_Cell3_20150114_1713_1Color_IntegratedResult.txt.gz","2555","HCC","patient 033","1","serum","HCC operation"
"GSM2281495","068-003","GSM2281495","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 068","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","367","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281495/suppl/GSM2281495_SH4XQ38_Cell4_20150114_1714_1Color_IntegratedResult.txt.gz","2555","HCC","patient 068","3","serum","HCC operation"
"GSM2281496","033-002","GSM2281496","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 033","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","369","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281496/suppl/GSM2281496_SH4XQ39_Cell1_20150114_1715_1Color_IntegratedResult.txt.gz","2555","HCC","patient 033","2","serum","HCC operation"
"GSM2281497","113-003","GSM2281497","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 113","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","370","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281497/suppl/GSM2281497_SH4XQ39_Cell2_20150114_1716_1Color_IntegratedResult.txt.gz","2555","HCC","patient 113","3","serum","HCC operation"
"GSM2281498","033-003","GSM2281498","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 033","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","373","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281498/suppl/GSM2281498_SH4XQ39_Cell3_20150114_1717_1Color_IntegratedResult.txt.gz","2555","HCC","patient 033","3","serum","HCC operation"
"GSM2281499","105-001","GSM2281499","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 105","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","374","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281499/suppl/GSM2281499_SH4XQ39_Cell4_20150114_1718_1Color_IntegratedResult.txt.gz","2555","HCC","patient 105","1","serum","HCC operation"
"GSM2281500","033-004","GSM2281500","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 033","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","376","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281500/suppl/GSM2281500_SH4XQ40_Cell1_20150114_1719_1Color_IntegratedResult.txt.gz","2555","HCC","patient 033","4","serum","HCC operation"
"GSM2281501","105-002","GSM2281501","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 105","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","377","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281501/suppl/GSM2281501_SH4XQ40_Cell2_20150114_1720_1Color_IntegratedResult.txt.gz","2555","HCC","patient 105","2","serum","HCC operation"
"GSM2281502","105-003","GSM2281502","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 105","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","382","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281502/suppl/GSM2281502_SH4XQ40_Cell3_20150114_1721_1Color_IntegratedResult.txt.gz","2555","HCC","patient 105","3","serum","HCC operation"
"GSM2281503","030-004","GSM2281503","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 030","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","383","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281503/suppl/GSM2281503_SH4XQ40_Cell4_20150114_1722_1Color_IntegratedResult.txt.gz","2555","HCC","patient 030","4","serum","HCC operation"
"GSM2281504","050-001","GSM2281504","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 050","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","385","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281504/suppl/GSM2281504_SH4XQ42_Cell1_20150114_1723_1Color_IntegratedResult.txt.gz","2555","HCC","patient 050","1","serum","HCC operation"
"GSM2281505","050-002","GSM2281505","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 050","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","387","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281505/suppl/GSM2281505_SH4XQ42_Cell2_20150114_1724_1Color_IntegratedResult.txt.gz","2555","HCC","patient 050","2","serum","HCC operation"
"GSM2281506","082-001","GSM2281506","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 082","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","388","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281506/suppl/GSM2281506_SH4XQ42_Cell3_20150114_1725_1Color_IntegratedResult.txt.gz","2555","HCC","patient 082","1","serum","HCC operation"
"GSM2281507","050-003","GSM2281507","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 050","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","389","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281507/suppl/GSM2281507_SH4XQ42_Cell4_20150114_1726_1Color_IntegratedResult.txt.gz","2555","HCC","patient 050","3","serum","HCC operation"
"GSM2281508","082-002","GSM2281508","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 082","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","391","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281508/suppl/GSM2281508_SH4XQ45_Cell1_20150114_1727_1Color_IntegratedResult.txt.gz","2555","HCC","patient 082","2","serum","HCC operation"
"GSM2281509","082-003","GSM2281509","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 082","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","396","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281509/suppl/GSM2281509_SH4XQ45_Cell2_20150114_1728_1Color_IntegratedResult.txt.gz","2555","HCC","patient 082","3","serum","HCC operation"
"GSM2281510","041-001","GSM2281510","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 041","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","397","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281510/suppl/GSM2281510_SH4XQ45_Cell3_20150114_1729_1Color_IntegratedResult.txt.gz","2555","HCC","patient 041","1","serum","HCC operation"
"GSM2281511","041-002","GSM2281511","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 041","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","402","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281511/suppl/GSM2281511_SH4XQ45_Cell4_20150114_1730_1Color_IntegratedResult.txt.gz","2555","HCC","patient 041","2","serum","HCC operation"
"GSM2281512","012-004","GSM2281512","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 012","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","406","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281512/suppl/GSM2281512_SH4XQ47_Cell1_20150114_1731_1Color_IntegratedResult.txt.gz","2555","HCC","patient 012","4","serum","HCC operation"
"GSM2281513","058-001","GSM2281513","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 058","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","408","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281513/suppl/GSM2281513_SH4XQ47_Cell2_20150114_1732_1Color_IntegratedResult.txt.gz","2555","HCC","patient 058","1","serum","HCC operation"
"GSM2281514","058-002","GSM2281514","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 058","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","411","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281514/suppl/GSM2281514_SH4XQ47_Cell3_20150114_1733_1Color_IntegratedResult.txt.gz","2555","HCC","patient 058","2","serum","HCC operation"
"GSM2281515","094-001","GSM2281515","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 094","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","425","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281515/suppl/GSM2281515_SH4XQ48_Cell1_20150114_1735_1Color_IntegratedResult.txt.gz","2555","HCC","patient 094","1","serum","HCC operation"
"GSM2281516","085-001","GSM2281516","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 085","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","426","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281516/suppl/GSM2281516_SH4XQ48_Cell2_20150114_1736_1Color_IntegratedResult.txt.gz","2555","HCC","patient 085","1","serum","HCC operation"
"GSM2281517","085-002","GSM2281517","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 085","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","428","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281517/suppl/GSM2281517_SH4XQ48_Cell3_20150114_1737_1Color_IntegratedResult.txt.gz","2555","HCC","patient 085","2","serum","HCC operation"
"GSM2281518","064-001","GSM2281518","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 064","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","429","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281518/suppl/GSM2281518_SH4XQ48_Cell4_20150114_1738_1Color_IntegratedResult.txt.gz","2555","HCC","patient 064","1","serum","HCC operation"
"GSM2281519","059-001","GSM2281519","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 059","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","430","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281519/suppl/GSM2281519_SH4XQ49_Cell1_20150114_1739_1Color_IntegratedResult.txt.gz","2555","HCC","patient 059","1","serum","HCC operation"
"GSM2281520","094-002","GSM2281520","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 094","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","432","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281520/suppl/GSM2281520_SH4XQ49_Cell2_20150114_1740_1Color_IntegratedResult.txt.gz","2555","HCC","patient 094","2","serum","HCC operation"
"GSM2281521","059-002","GSM2281521","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 059","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","433","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281521/suppl/GSM2281521_SH4XQ49_Cell3_20150114_1741_1Color_IntegratedResult.txt.gz","2555","HCC","patient 059","2","serum","HCC operation"
"GSM2281522","064-002","GSM2281522","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 064","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","438","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281522/suppl/GSM2281522_SH4XQ49_Cell4_20150114_1742_1Color_IntegratedResult.txt.gz","2555","HCC","patient 064","2","serum","HCC operation"
"GSM2281523","094-003","GSM2281523","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 094","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","439","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281523/suppl/GSM2281523_SH4XQ51_Cell1_20150114_1743_1Color_IntegratedResult.txt.gz","2555","HCC","patient 094","3","serum","HCC operation"
"GSM2281524","066-001","GSM2281524","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 066","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","440","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281524/suppl/GSM2281524_SH4XQ51_Cell2_20150114_1744_1Color_IntegratedResult.txt.gz","2555","HCC","patient 066","1","serum","HCC operation"
"GSM2281525","064-003","GSM2281525","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 064","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","441","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281525/suppl/GSM2281525_SH4XQ51_Cell3_20150114_1745_1Color_IntegratedResult.txt.gz","2555","HCC","patient 064","3","serum","HCC operation"
"GSM2281526","059-003","GSM2281526","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 059","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","442","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281526/suppl/GSM2281526_SH4XQ51_Cell4_20150114_1746_1Color_IntegratedResult.txt.gz","2555","HCC","patient 059","3","serum","HCC operation"
"GSM2281527","066-002","GSM2281527","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 066","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","444","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281527/suppl/GSM2281527_SH4XQ52_Cell1_20150114_1747_1Color_IntegratedResult.txt.gz","2555","HCC","patient 066","2","serum","HCC operation"
"GSM2281528","092-001","GSM2281528","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 092","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","447","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281528/suppl/GSM2281528_SH4XQ52_Cell2_20150114_1748_1Color_IntegratedResult.txt.gz","2555","HCC","patient 092","1","serum","HCC operation"
"GSM2281529","092-002","GSM2281529","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 092","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","448","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281529/suppl/GSM2281529_SH4XQ52_Cell3_20150114_1749_1Color_IntegratedResult.txt.gz","2555","HCC","patient 092","2","serum","HCC operation"
"GSM2281530","081-001","GSM2281530","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 081","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","452","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281530/suppl/GSM2281530_SH4XQ52_Cell4_20150114_1750_1Color_IntegratedResult.txt.gz","2555","HCC","patient 081","1","serum","HCC operation"
"GSM2281531","026-001","GSM2281531","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 026","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","453","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281531/suppl/GSM2281531_SH4XQ53_Cell1_20150114_1751_1Color_IntegratedResult.txt.gz","2555","HCC","patient 026","1","serum","HCC operation"
"GSM2281532","081-002","GSM2281532","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 081","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","454","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281532/suppl/GSM2281532_SH4XQ53_Cell2_20150114_1752_1Color_IntegratedResult.txt.gz","2555","HCC","patient 081","2","serum","HCC operation"
"GSM2281533","055-001","GSM2281533","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 055","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","455","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281533/suppl/GSM2281533_SH4XQ53_Cell3_20150114_1753_1Color_IntegratedResult.txt.gz","2555","HCC","patient 055","1","serum","HCC operation"
"GSM2281534","026-002","GSM2281534","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 026","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","456","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281534/suppl/GSM2281534_SH4XQ53_Cell4_20150114_1754_1Color_IntegratedResult.txt.gz","2555","HCC","patient 026","2","serum","HCC operation"
"GSM2281535","062-001","GSM2281535","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 062","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","457","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281535/suppl/GSM2281535_SH4XQ54_Cell1_20150114_1755_1Color_IntegratedResult.txt.gz","2555","HCC","patient 062","1","serum","HCC operation"
"GSM2281536","055-002","GSM2281536","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 055","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","459","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281536/suppl/GSM2281536_SH4XQ54_Cell2_20150114_1756_1Color_IntegratedResult.txt.gz","2555","HCC","patient 055","2","serum","HCC operation"
"GSM2281537","026-003","GSM2281537","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 026","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","462","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281537/suppl/GSM2281537_SH4XQ54_Cell3_20150114_1757_1Color_IntegratedResult.txt.gz","2555","HCC","patient 026","3","serum","HCC operation"
"GSM2281538","037-001","GSM2281538","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 037","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","463","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281538/suppl/GSM2281538_SH4XQ54_Cell4_20150114_1758_1Color_IntegratedResult.txt.gz","2555","HCC","patient 037","1","serum","HCC operation"
"GSM2281539","056-001","GSM2281539","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 056","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","464","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281539/suppl/GSM2281539_SH4XQ55_Cell1_20150114_1759_1Color_IntegratedResult.txt.gz","2555","HCC","patient 056","1","serum","HCC operation"
"GSM2281540","023-001","GSM2281540","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 023","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","465","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281540/suppl/GSM2281540_SH4XQ55_Cell2_20150114_1800_1Color_IntegratedResult.txt.gz","2555","HCC","patient 023","1","serum","HCC operation"
"GSM2281541","052-001","GSM2281541","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 052","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","466","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281541/suppl/GSM2281541_SH4XQ55_Cell3_20150114_1801_1Color_IntegratedResult.txt.gz","2555","HCC","patient 052","1","serum","HCC operation"
"GSM2281542","023-002","GSM2281542","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 023","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","468","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281542/suppl/GSM2281542_SH4XQ55_Cell4_20150114_1802_1Color_IntegratedResult.txt.gz","2555","HCC","patient 023","2","serum","HCC operation"
"GSM2281543","037-002","GSM2281543","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 037","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","469","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281543/suppl/GSM2281543_SH4XQ56_Cell1_20150114_1803_1Color_IntegratedResult.txt.gz","2555","HCC","patient 037","2","serum","HCC operation"
"GSM2281544","052-002","GSM2281544","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 052","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","470","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281544/suppl/GSM2281544_SH4XQ56_Cell2_20150114_1804_1Color_IntegratedResult.txt.gz","2555","HCC","patient 052","2","serum","HCC operation"
"GSM2281545","055-003","GSM2281545","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 055","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","473","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281545/suppl/GSM2281545_SH4XQ56_Cell3_20150114_1805_1Color_IntegratedResult.txt.gz","2555","HCC","patient 055","3","serum","HCC operation"
"GSM2281546","027-001","GSM2281546","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 027","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","474","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281546/suppl/GSM2281546_SH4XQ56_Cell4_20150114_1806_1Color_IntegratedResult.txt.gz","2555","HCC","patient 027","1","serum","HCC operation"
"GSM2281547","027-002","GSM2281547","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 027","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","478","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281547/suppl/GSM2281547_SH4XQ57_Cell1_20150114_1807_1Color_IntegratedResult.txt.gz","2555","HCC","patient 027","2","serum","HCC operation"
"GSM2281548","056-002","GSM2281548","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 056","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","483","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281548/suppl/GSM2281548_SH4XQ57_Cell2_20150114_1808_1Color_IntegratedResult.txt.gz","2555","HCC","patient 056","2","serum","HCC operation"
"GSM2281549","020-001","GSM2281549","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 020","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","484","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281549/suppl/GSM2281549_SH4XQ57_Cell3_20150114_1809_1Color_IntegratedResult.txt.gz","2555","HCC","patient 020","1","serum","HCC operation"
"GSM2281550","056-003","GSM2281550","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 056","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","487","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281550/suppl/GSM2281550_SH4XQ57_Cell4_20150114_1810_1Color_IntegratedResult.txt.gz","2555","HCC","patient 056","3","serum","HCC operation"
"GSM2281551","074-001","GSM2281551","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 074","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","489","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281551/suppl/GSM2281551_SH4XQ58_Cell1_20150114_1811_1Color_IntegratedResult.txt.gz","2555","HCC","patient 074","1","serum","HCC operation"
"GSM2281552","011-004","GSM2281552","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 011","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","491","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281552/suppl/GSM2281552_SH4XQ58_Cell2_20150114_1812_1Color_IntegratedResult.txt.gz","2555","HCC","patient 011","4","serum","HCC operation"
"GSM2281553","074-002","GSM2281553","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 074","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","493","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281553/suppl/GSM2281553_SH4XQ58_Cell3_20150114_1813_1Color_IntegratedResult.txt.gz","2555","HCC","patient 074","2","serum","HCC operation"
"GSM2281554","079-001","GSM2281554","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 079","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","495","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281554/suppl/GSM2281554_SH4XQ58_Cell4_20150114_1814_1Color_IntegratedResult.txt.gz","2555","HCC","patient 079","1","serum","HCC operation"
"GSM2281555","079-002","GSM2281555","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 079","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","499","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281555/suppl/GSM2281555_SH4XQ59_Cell1_20150114_1815_1Color_IntegratedResult.txt.gz","2555","HCC","patient 079","2","serum","HCC operation"
"GSM2281556","015-003","GSM2281556","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 015","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","501","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281556/suppl/GSM2281556_SH4XQ59_Cell2_20150114_1816_1Color_IntegratedResult.txt.gz","2555","HCC","patient 015","3","serum","HCC operation"
"GSM2281557","020-002","GSM2281557","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 020","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","506","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281557/suppl/GSM2281557_SH4XQ59_Cell3_20150114_1817_1Color_IntegratedResult.txt.gz","2555","HCC","patient 020","2","serum","HCC operation"
"GSM2281558","053-001","GSM2281558","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 053","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","507","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281558/suppl/GSM2281558_SH4XQ59_Cell4_20150114_1818_1Color_IntegratedResult.txt.gz","2555","HCC","patient 053","1","serum","HCC operation"
"GSM2281559","053-002","GSM2281559","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 053","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","511","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281559/suppl/GSM2281559_SH4XQ60_Cell1_20150114_1819_1Color_IntegratedResult.txt.gz","2555","HCC","patient 053","2","serum","HCC operation"
"GSM2281560","040-001","GSM2281560","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 040","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","512","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281560/suppl/GSM2281560_SH4XQ60_Cell2_20150114_1820_1Color_IntegratedResult.txt.gz","2555","HCC","patient 040","1","serum","HCC operation"
"GSM2281561","071-001","GSM2281561","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 071","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","513","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281561/suppl/GSM2281561_SH4XQ60_Cell3_20150114_1821_1Color_IntegratedResult.txt.gz","2555","HCC","patient 071","1","serum","HCC operation"
"GSM2281562","091-003","GSM2281562","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 091","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","520","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281562/suppl/GSM2281562_SH4XQ60_Cell4_20150114_1822_1Color_IntegratedResult.txt.gz","2555","HCC","patient 091","3","serum","HCC operation"
"GSM2281563","043-001","GSM2281563","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 043","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","521","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281563/suppl/GSM2281563_SH4XT01_Cell1_20150114_1823_1Color_IntegratedResult.txt.gz","2555","HCC","patient 043","1","serum","HCC operation"
"GSM2281564","062-002","GSM2281564","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 062","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","522","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281564/suppl/GSM2281564_SH4XT01_Cell2_20150114_1824_1Color_IntegratedResult.txt.gz","2555","HCC","patient 062","2","serum","HCC operation"
"GSM2281565","043-002","GSM2281565","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 043","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","523","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281565/suppl/GSM2281565_SH4XT01_Cell3_20150114_1825_1Color_IntegratedResult.txt.gz","2555","HCC","patient 043","2","serum","HCC operation"
"GSM2281566","088-001","GSM2281566","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 088","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","524","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281566/suppl/GSM2281566_SH4XT01_Cell4_20150114_1826_1Color_IntegratedResult.txt.gz","2555","HCC","patient 088","1","serum","HCC operation"
"GSM2281567","088-002","GSM2281567","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 088","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","525","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281567/suppl/GSM2281567_SH4XT04_Cell1_20150114_1827_1Color_IntegratedResult.txt.gz","2555","HCC","patient 088","2","serum","HCC operation"
"GSM2281568","077-001","GSM2281568","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 077","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","526","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281568/suppl/GSM2281568_SH4XT04_Cell2_20150114_1828_1Color_IntegratedResult.txt.gz","2555","HCC","patient 077","1","serum","HCC operation"
"GSM2281569","043-003","GSM2281569","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 043","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","527","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281569/suppl/GSM2281569_SH4XT04_Cell3_20150114_1829_1Color_IntegratedResult.txt.gz","2555","HCC","patient 043","3","serum","HCC operation"
"GSM2281570","077-002","GSM2281570","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 077","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","529","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281570/suppl/GSM2281570_SH4XT04_Cell4_20150114_1830_1Color_IntegratedResult.txt.gz","2555","HCC","patient 077","2","serum","HCC operation"
"GSM2281571","065-001","GSM2281571","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 065","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","530","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281571/suppl/GSM2281571_SH4XT05_Cell1_20150115_2222_1Color_IntegratedResult.txt.gz","2555","HCC","patient 065","1","serum","HCC operation"
"GSM2281572","040-002","GSM2281572","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 040","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","531","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281572/suppl/GSM2281572_SH4XT05_Cell2_20150115_2223_1Color_IntegratedResult.txt.gz","2555","HCC","patient 040","2","serum","HCC operation"
"GSM2281573","093-003","GSM2281573","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 093","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","533","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281573/suppl/GSM2281573_SH4XT05_Cell3_20150115_2224_1Color_IntegratedResult.txt.gz","2555","HCC","patient 093","3","serum","HCC operation"
"GSM2281574","065-002","GSM2281574","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 065","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","535","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281574/suppl/GSM2281574_SH4XT05_Cell4_20150115_2225_1Color_IntegratedResult.txt.gz","2555","HCC","patient 065","2","serum","HCC operation"
"GSM2281575","067-001","GSM2281575","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 067","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","540","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281575/suppl/GSM2281575_SH4XT07_Cell1_20150115_2226_1Color_IntegratedResult.txt.gz","2555","HCC","patient 067","1","serum","HCC operation"
"GSM2281576","067-002","GSM2281576","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 067","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","542","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281576/suppl/GSM2281576_SH4XT07_Cell2_20150115_2227_1Color_IntegratedResult.txt.gz","2555","HCC","patient 067","2","serum","HCC operation"
"GSM2281577","013-001","GSM2281577","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 013","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","546","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281577/suppl/GSM2281577_SH4XT07_Cell3_20150115_2228_1Color_IntegratedResult.txt.gz","2555","HCC","patient 013","1","serum","HCC operation"
"GSM2281578","025-001","GSM2281578","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 025","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","547","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281578/suppl/GSM2281578_SH4XT07_Cell4_20150115_2229_1Color_IntegratedResult.txt.gz","2555","HCC","patient 025","1","serum","HCC operation"
"GSM2281579","013-002","GSM2281579","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 013","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","548","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281579/suppl/GSM2281579_SH4XT08_Cell1_20150115_2230_1Color_IntegratedResult.txt.gz","2555","HCC","patient 013","2","serum","HCC operation"
"GSM2281580","025-002","GSM2281580","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 025","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","549","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281580/suppl/GSM2281580_SH4XT08_Cell2_20150115_2231_1Color_IntegratedResult.txt.gz","2555","HCC","patient 025","2","serum","HCC operation"
"GSM2281581","013-003","GSM2281581","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 013","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 3","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","554","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281581/suppl/GSM2281581_SH4XT08_Cell3_20150115_2232_1Color_IntegratedResult.txt.gz","2555","HCC","patient 013","3","serum","HCC operation"
"GSM2281582","071-002","GSM2281582","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 071","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","556","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281582/suppl/GSM2281582_SH4XT08_Cell4_20150115_2233_1Color_IntegratedResult.txt.gz","2555","HCC","patient 071","2","serum","HCC operation"
"GSM2281583","048-004","GSM2281583","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 048","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","558","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281583/suppl/GSM2281583_SH4XT09_Cell1_20150115_2234_1Color_IntegratedResult.txt.gz","2555","HCC","patient 048","4","serum","HCC operation"
"GSM2281584","015-004","GSM2281584","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 015","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","562","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281584/suppl/GSM2281584_SH4XT09_Cell2_20150115_2235_1Color_IntegratedResult.txt.gz","2555","HCC","patient 015","4","serum","HCC operation"
"GSM2281585","045-001","GSM2281585","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 045","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","563","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281585/suppl/GSM2281585_SH4XT09_Cell3_20150115_2236_1Color_IntegratedResult.txt.gz","2555","HCC","patient 045","1","serum","HCC operation"
"GSM2281586","054-001","GSM2281586","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 054","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 1","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","564","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281586/suppl/GSM2281586_SH4XT09_Cell4_20150115_2237_1Color_IntegratedResult.txt.gz","2555","HCC","patient 054","1","serum","HCC operation"
"GSM2281587","028-004","GSM2281587","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 028","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","72","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281587/suppl/GSM2281587_SH4XX44_Cell4_20150308_1929_1Color_IntegratedResult.txt.gz","2555","HCC","patient 028","4","serum","HCC operation"
"GSM2281588","012-005","GSM2281588","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 012","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 5","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","81","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281588/suppl/GSM2281588_SH4XX45_Cell1_20150308_1930_1Color_IntegratedResult.txt.gz","2555","HCC","patient 012","5","serum","HCC operation"
"GSM2281589","044-002","GSM2281589","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 044","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","578","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281589/suppl/GSM2281589_SH4XX45_Cell2_20150308_1931_1Color_IntegratedResult.txt.gz","2555","HCC","patient 044","2","serum","HCC operation"
"GSM2281590","022-002","GSM2281590","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 022","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 2","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","581","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281590/suppl/GSM2281590_SH4XX45_Cell3_20150308_1932_1Color_IntegratedResult.txt.gz","2555","HCC","patient 022","2","serum","HCC operation"
"GSM2281599","073-004","GSM2281599","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 073","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","158","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281599/suppl/GSM2281599_SH51Y67_Cell4_20150308_1937_1Color_IntegratedResult.txt.gz","2555","HCC","patient 073","4","serum","HCC operation"
"GSM2281600","068-004","GSM2281600","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 068","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","263","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281600/suppl/GSM2281600_SH51Z01_Cell1_20150308_1938_1Color_IntegratedResult.txt.gz","2555","HCC","patient 068","4","serum","HCC operation"
"GSM2281601","057-004","GSM2281601","Public on Dec 31 2016","Aug 16 2016","Dec 31 2016","RNA","1","serum","Homo sapiens","individual: patient 057","disease state: HCC","treatment: HCC operation","order in which blood was collected during treatment: 4","sample: serum","total RNA","RNA samples were extracted from serum using 3D-Gene RNA extraction reagent from liquid sampld (Toray Industries Inc., Tokyo, Japan)..","Cy5","Extracted total RNA was labeled with Cy5 using the 3D-Gene miRNA labeling kit (Toray Industries Inc., Tokyo, Japan).","9606","Hybridized for 16 h at 37 C with rotary shake (250 rpm). Hybridization buffer and washing protocol was followed by the protocol supplied by TORAY Industries, Inc..","3D-Gene Scanner ((Toray Industries Inc., Tokyo, Japan) was used for scanning. Images were quantified using Extraction(Toray Industries Inc., Tokyo, Japan).","hepatocacellular carcinoma (HCC)","421","The raw data of each spot was normalized by substitution with a mean intensity of the background signal determined by all blank spots’ signal intensities of 95% confidence intervals.","GPL18941","Satoshi,,Kondo","Toray Industries,Inc.","10-1 tebiro 6-chome","Kamakura","Kanagawa","248-8555","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2281nnn/GSM2281601/suppl/GSM2281601_SH51Z01_Cell2_20150308_1939_1Color_IntegratedResult.txt.gz","2555","HCC","patient 057","4","serum","HCC operation"
